Listed by the USPTO as THUESON, HANNA MARIE
Tech Center 1600 • Art Units: 1600 1611 1612 1632 1638
This examiner grants 77% of resolved cases
Hanna Marie Thueson has handled 30 resolved cases in Tech Center 1600 and Art Unit 1600. The examiner's allowance rate is 76.7 percent. For applications that are granted, the median time to allowance is 1284 days. This 1284-day figure provides a timeline for applicants in the 1600 tech center.
The interview lift is 28.2 percent, indicating that interviews are quite effective for this examiner. This lift is measured against the 76.7 percent baseline allowance rate and suggests a strong benefit to direct communication. Companies such as The Regents of the University of California, Cellartgen Inc., and Canon Inc. have appeared in this docket.
Firms like Joseph R. Baker, APC, NOVICK, KIM & LEE, PLLC, and Barron & Young PLLC represent these clients. With 30 cases resolved, the 76.7 percent rate is based on a limited history. However, the 28.2 percent lift is a significant factor for practitioners.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19077772 | CELL DETACHMENT METHOD AND CELL DETACHMENT SYSTEM | Non-Final OA | CANON KABUSHIKI KAISHA |
| 18569550 | PRIMORDIAL GERM CELLS | Non-Final OA | The Regents of the University of California |
| 18354719 | METHOD FOR PRODUCING FOOD PRODUCTS USING CELLS GROWN IN CULTURE AS AN ALTERNATIVE TO ANIMAL HUSBANDRY | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18028740 | COMPOSITION AND METHODS FOR MODULATING TCF4 GENE EXPESSION AND TREATING PITT HOPKINS SYNDROME | Non-Final OA | The Regents of the University of California |
| 18074402 | ENGINEERED VASCULARIZED ORGANOIDS | Non-Final OA | The Regents of the University of California |
| 18961853 | Single Cell Encapsulation in Compartmentalized Hydrogel Coatings | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18040971 | RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF GRN-ASSOCIATED ADULT-ONSET NEURODEGENERATION | Final Rejection | The Trustees of the University of Pennsylvania |
| 18862323 | PATIENT-DERIVED CELL-CONTAINING DROPLETS ENABLE CLINICAL PRECISION ONCOLOGY | Non-Final OA | Duke University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy76.7% of resolved applications examined by Hanna Marie Thueson were allowed (30 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +28.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Hanna Marie Thueson took 1,284 days on average from filing to allowance.
Hanna Marie Thueson examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
